Posted on Monday, April 24, 2017
Legacy Systems! Integration! Security Firewalls! Regulatory! Here are just some of the reasons banks are struggling with their blockchain implementations. Why are so many POC’s taking so long to get to production? Because the POC’s are not answering all the questions the business needs to address before getting additional funding for a production release. This is becoming an all too familiar scenario within the banks. When Blockchain companies were identifying Use Cases, they were basing the assumption on systems and
Posted on Tuesday, March 7, 2017
Trade Finance is the lifeblood of international trade. The WTO estimates that 80-90% of all global trade relies on Trade Finance and it is TRUST that drives trade finance.
Without a trusted intermediary, there is no guarantee that a seller would receive payment for the goods they sold and the buyer would have no guarantee that they would receive the goods they purchased. By having a bank or other intermediary finance the transaction, both parties can be assured that payment will
Posted on Wednesday, January 4, 2017
Happy New Year and welcome 2017! With a new year among us and many companies anxious to get started with their first Blockchain solution, there are several non-technical or functional components to consider when implementing a Blockchain. Although many of us are accustomed to downloading apps to our phones or tablets and we are off and running, the Blockchain doesn’t fall into this category. Whether you are in Banking, Pharma or Retail, implementing a Blockchain leaves several questions to be
Posted on Thursday, September 8, 2016
Every major financial institution (Commercial Banks, Central Banks, and Stock Exchanges) is determining how best to leverage Advanced Digital Ledger Technology™ (ADLT™) to improve operations. Whether it is for trade finance, supply chain, letters of credit, official digital versions of fiat currencies, or securing equity transactions, these institutions want to find a way to leverage ADLT™ within their current IT infrastructure and processes to save money and improve service levels.
Unlike other industries, e.g. biopharma, that have a regulatory mandate to